Cardiac Sarcoidosis Clinical Trials

12 recruiting

Cardiac Sarcoidosis Trials at a Glance

11 actively recruiting trials for cardiac sarcoidosis are listed on ClinicalTrialsFinder across 6 cities in 9 countries. The largest study group is Phase 2 with 3 trials, with the heaviest enrollment activity in Hamilton, Montreal, and Halifax. Lead sponsors running cardiac sarcoidosis studies include Ottawa Heart Institute Research Corporation, Duke University, and Chinese Academy of Medical Sciences, Fuwai Hospital.

Browse cardiac sarcoidosis trials by phase

Treatments under study

About Cardiac Sarcoidosis Clinical Trials

Looking for clinical trials for Cardiac Sarcoidosis? There are currently 12 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Cardiac Sarcoidosis trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Cardiac Sarcoidosis clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 111 of 11 trials

Recruiting
Phase 2

Repurposing Tilmanocept for Cardiac Sarcoidosis

Cardiac Sarcoidosis
Duke University15 enrolled1 locationNCT07159074
Recruiting

Precision Diagnosis and Risk Stratification of Rare Cardiomyopathies Based on Novel Cardiac Magnetic Resonance Techniques

Noonan SyndromeFabry DiseaseCardiac Amyloidosis+4 more
Chinese Academy of Medical Sciences, Fuwai Hospital1,000 enrolled1 locationNCT07336394
Recruiting

Diagnostic Utility of SGLT1/2 Inhibition to Facilitate Myocardial Glucose Suppression

Cardiac Sarcoidosis
University of Pennsylvania40 enrolled1 locationNCT06510894
Recruiting

Cardiomyopathies and Heart Muscle Diseases: Cardiac Imaging in the Evaluation of Myocardial Fibrosis Transition

Hypertrophic CardiomyopathyMyocarditisHeart Failure With Preserved Ejection Fraction+4 more
University of Edinburgh290 enrolled1 locationNCT06409585
Recruiting
Phase 2

Rilonacept in Subjects With Cardiac Sarcoidosis

Cardiac Sarcoidosis
Mayo Clinic60 enrolled2 locationsNCT06660732
Recruiting
Not Applicable

Evaluation of the Prognostic Value of PET/MRI in Cardiac Sarcoidosis

Cardiac Sarcoidosis
Assistance Publique - Hôpitaux de Paris180 enrolled1 locationNCT05954507
Recruiting
Phase 2

[68Ga]Ga-PentixaFor PET/CT in Acute Myocardial Inflammation

Myocarditis Due to DrugCardiac SarcoidosisAcute Cellular Graft Rejection
John O. Prior69 enrolled1 locationNCT05499637
Recruiting
Phase 3

Cardiac Sarcoidosis Randomized Trial

SarcoidosisCardiac Sarcoidosis
Ottawa Heart Institute Research Corporation194 enrolled30 locationsNCT03593759
Recruiting

Cardiac Sarcoidosis Multi-Center Prospective Cohort

Cardiac Sarcoidosis
Ottawa Heart Institute Research Corporation1,500 enrolled14 locationsNCT01477359
Recruiting

Macrophage PET/CT Imaging Using 64Cu-DOTATATE for the Diagnosis of Cardiac Sarcoidosis

Cardiac Sarcoidosis
Rigshospitalet, Denmark76 enrolled1 locationNCT06131112
Recruiting

Diagnostic Criteria in Cardiac Sarcoidosis

Cardiac Sarcoidosis
Heart Center Leipzig - University Hospital100 enrolled1 locationNCT04737317